1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

NCT04493320 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Study terminated by sponsor (NIMH)

Conditions

Depression
Cognitive Impairment
Gait Impairment

Interventions

DRUG: Carbidopa/levodopa
DRUG: Placebo

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]